Cited 41 time in
Neuroprotective Effect of Low Frequency-Pulsed Electromagnetic Fields in Ischemic Stroke
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Urnukhsaikhan, Enerelt | - |
| dc.contributor.author | Mishig-Ochir, Tsogbadrakh | - |
| dc.contributor.author | Kim, Soo-Chan | - |
| dc.contributor.author | Park, Jung-Keug | - |
| dc.contributor.author | Seo, Young-Kwon | - |
| dc.date.accessioned | 2024-08-08T01:02:02Z | - |
| dc.date.available | 2024-08-08T01:02:02Z | - |
| dc.date.issued | 2017-04 | - |
| dc.identifier.issn | 0273-2289 | - |
| dc.identifier.issn | 1559-0291 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/14856 | - |
| dc.description.abstract | Low frequency-pulsed electromagnetic fields (LF-PEMFs) affect many biological processes; however, the fundamental mechanisms responsible for these effects remain unclear. Our study aimed to investigate the effect of LF-PEMFs on neuroprotection after ischemic stroke. C57B6 mice were exposed to LF-PEMF (F = 60 Hz, Bm = 10 mT) after photothrombotic occlusion. We measured the BDNF/TrkB/Akt signaling pathway, pro-apoptotic and pro-survival protein and gene expressions, and the expression of inflammatory mediators and performed behavioral tests in both LF-PEMF-treated and untreated ischemic stroke mice. Our results showed that LF-PEMF treatment promotes activation of the BDNF/TrkB/Akt signaling pathway. Subsequently, pro-survival proteins were significantly increased, while pro-apoptotic proteins and inflammatory mediators were decreased in ischemic stroke mice after LF-PEMF treatment. The results demonstrated that LF-PEMF exposure has a neuroprotective effect after ischemic stroke in mice during the recovery process. | - |
| dc.format.extent | 12 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPRINGER | - |
| dc.title | Neuroprotective Effect of Low Frequency-Pulsed Electromagnetic Fields in Ischemic Stroke | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1007/s12010-016-2289-z | - |
| dc.identifier.scopusid | 2-s2.0-84991787645 | - |
| dc.identifier.wosid | 000399194800009 | - |
| dc.identifier.bibliographicCitation | APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, v.181, no.4, pp 1360 - 1371 | - |
| dc.citation.title | APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | - |
| dc.citation.volume | 181 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 1360 | - |
| dc.citation.endPage | 1371 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
| dc.subject.keywordPlus | OSTEOGENIC DIFFERENTIATION | - |
| dc.subject.keywordPlus | CELL-PROLIFERATION | - |
| dc.subject.keywordPlus | STEM-CELLS | - |
| dc.subject.keywordPlus | SURVIVAL | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | BCL-2 | - |
| dc.subject.keywordPlus | PLAY | - |
| dc.subject.keywordPlus | BAD | - |
| dc.subject.keywordAuthor | Apoptosis | - |
| dc.subject.keywordAuthor | BDNF | - |
| dc.subject.keywordAuthor | Inflammation | - |
| dc.subject.keywordAuthor | Ischemic stroke | - |
| dc.subject.keywordAuthor | LF-PEMF | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
